Impact of Chewing Gum on FeNO Levels in Patients With Bronchial Asthma

NANot yet recruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

August 1, 2025

Primary Completion Date

November 30, 2026

Study Completion Date

December 30, 2026

Conditions
Asthma BronchialeFeNOChewing Gum
Interventions
OTHER

Chewing Gum

Patients admitted to our outpatient clinic for bronchial asthma undergo regular FeNO measurements. If the value is ≥ 25 ppb (elevated), the patients are randomized into two groups after obtaining their consent. In the control group, a FeNO measurement is performed again after 15 minutes. In the second group, the FeNO measurement is measured again after 15 minutes of consuming sugar-free, antioxidant-containing chewing gum. The following data are then collected and documented from the patients: age, gender, height, weight, smoking status, current medication, other illnesses, whole body lung function test, and laboratory tests (eosinophils, IgE). Participation in the study will not change the course of the patient's stay in our clinic.

Trial Locations (1)

52074

Department of Pneumology and Intensive Care Medicine, RWTH Aachen University Hospital, Aachen

All Listed Sponsors
lead

RWTH Aachen University

OTHER

NCT07053956 - Impact of Chewing Gum on FeNO Levels in Patients With Bronchial Asthma | Biotech Hunter | Biotech Hunter